Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
Company Blog Articles
Dr. Robert Hariri, CEO and founder of Celularity, discusses how the company is exploring a new treatment for COVID-19 as...
The FDA cleared an investigational new drug application for CYNK-001 for the treatment of adults with COVID-19 infection, according to...
Celularity, a New Jersey company developing experimental cancer treatments derived from human placentas, has received the FDA’s blessing to kick...
